BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

181 related articles for article (PubMed ID: 9179366)

  • 1. Mistletoe extract-induced effects on immunocompetent cells: in vitro studies.
    Stein GM; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S39-42. PubMed ID: 9179366
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Mistletoe (viscum album) lectins as cytokine inducers and immunoadjuvant in tumor therapy. A review.
    Bocci V
    J Biol Regul Homeost Agents; 1993; 7(1):1-6. PubMed ID: 8346712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effect of a recombinant lectin, Viscum album agglutinin on the secretion of interleukin-12 in cultured human peripheral blood mononuclear cells and on NK-cell-mediated cytotoxicity of rat splenocytes in vitro and in vivo.
    Hajto T; Hostanska K; Weber K; Zinke H; Fischer J; Mengs U; Lentzen H; Saller R
    Nat Immun; 1998; 16(1):34-46. PubMed ID: 9789123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of the effects of Viscum album lectin ML-1 and fresh plant extract (Isorel) on the cell growth in vitro and tumorigenicity of melanoma B16F10.
    Zarković N; Kalisnik T; Loncarić I; Borović S; Mang S; Kissel D; Konitzer M; Jurin M; Grainza S
    Cancer Biother Radiopharm; 1998 Apr; 13(2):121-31. PubMed ID: 10850348
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Influence of polysaccharides from Viscum album L. on human lymphocytes, monocytes and granulocytes in vitro.
    Stein GM; Edlund U; Pfüller U; Büssing A; Schietzel M
    Anticancer Res; 1999; 19(5B):3907-14. PubMed ID: 10628330
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Modulation of cytotoxicity and enhancement of cytokine release induced by Viscum album L. extracts or mistletoe lectins.
    Ribéreau-Gayon G; Jung ML; Frantz M; Anton R
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S3-8. PubMed ID: 9179359
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Inability of galactoside-specific mistletoe lectin to inhibit N-methyl-N-nitrosourea-induced tumor development in the urinary bladder of rats and to mediate a local cellular immune response after long-term administration.
    Kunze E; Schulz H; Gabius HJ
    J Cancer Res Clin Oncol; 1998; 124(2):73-87. PubMed ID: 9654190
    [TBL] [Abstract][Full Text] [Related]  

  • 8. From ill-defined extracts to the immunomodulatory lectin: will there be a reason for oncological application of mistletoe?
    Gabius HJ; Gabius S; Joshi SS; Koch B; Schroeder M; Manzke WM; Westerhausen M
    Planta Med; 1994 Feb; 60(1):2-7. PubMed ID: 8134410
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Non-lectin component in a fermented extract from Viscum album L. grown on pines induces proliferation of lymphocytes from healthy and allergic individuals in vitro.
    Stein G; Berg PA
    Eur J Clin Pharmacol; 1994; 47(1):33-8. PubMed ID: 7988621
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Clinical relevance of immunoactive mistletoe lectin-I.
    Beuth J
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S53-5. PubMed ID: 9179369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Flow cytometric analyses of the specific activation of peripheral blood mononuclear cells from healthy donors after in vitro stimulation with a fermented mistletoe extract and mistletoe lectins.
    Stein GM; Berg PA
    Eur J Cancer; 1998 Jun; 34(7):1105-10. PubMed ID: 9849462
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Release of cytokines by a fermented lectin-1 (ML-1) free mistletoe extract reflects differences in the reactivity of PBMC in healthy and allergic individuals and tumour patients.
    Stein GM; Meink H; Durst J; Berg PA
    Eur J Clin Pharmacol; 1996; 51(3-4):247-52. PubMed ID: 9010693
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Characterization of cytotoxic proteins from mistletoe (Viscum album L.).
    Jung ML; Baudino S; Ribéreau-Gayon G; Beck JP
    Cancer Lett; 1990 May; 51(2):103-8. PubMed ID: 2344587
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Differences in the apoptosis-inducing properties of Viscum album L. extracts.
    Büssing A; Suzart K; Schweizer K
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S9-14. PubMed ID: 9179360
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Induction of anti-mistletoe lectin antibodies in relation to different mistletoe-extracts.
    Stein GM; Stettin A; Schultze J; Berg PA
    Anticancer Drugs; 1997 Apr; 8 Suppl 1():S57-9. PubMed ID: 9179370
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiproliferative potential from aqueous Viscum album L. preparations and their main constituents in comparison with ricin and purothionin on human cancer cells.
    Felenda JE; Turek C; Stintzing FC
    J Ethnopharmacol; 2019 May; 236():100-107. PubMed ID: 30840914
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Mistletoe therapy from the pharmacologic perspective].
    Hajto T; Hostanska K; Saller R
    Forsch Komplementarmed; 1999 Aug; 6(4):186-94. PubMed ID: 10529578
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Induction of apoptosis in human lymphocytes treated with Viscum album L. is mediated by the mistletoe lectins.
    Büssing A; Suzart K; Bergmann J; Pfüller U; Schietzel M; Schweizer K
    Cancer Lett; 1996 Jan; 99(1):59-72. PubMed ID: 8564930
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Cellular and humoral adjuvant activity of lectins isolated from Korean mistletoe (Viscum album colaratum).
    Yoon TJ; Yoo YC; Kang TB; Her E; Kim SH; Kim K; Azuma I; Kim JB
    Int Immunopharmacol; 2001 May; 1(5):881-9. PubMed ID: 11379043
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Ingredients of mistletoe (Viscum album L.) as potential drugs].
    Franz H
    Pharmazie; 1985 Feb; 40(2):97-104. PubMed ID: 3889937
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 10.